全文获取类型
收费全文 | 37585篇 |
免费 | 1975篇 |
国内免费 | 287篇 |
专业分类
耳鼻咽喉 | 296篇 |
儿科学 | 920篇 |
妇产科学 | 844篇 |
基础医学 | 4251篇 |
口腔科学 | 729篇 |
临床医学 | 3145篇 |
内科学 | 10425篇 |
皮肤病学 | 760篇 |
神经病学 | 3507篇 |
特种医学 | 1525篇 |
外科学 | 5810篇 |
综合类 | 89篇 |
一般理论 | 6篇 |
预防医学 | 1387篇 |
眼科学 | 446篇 |
药学 | 2217篇 |
中国医学 | 59篇 |
肿瘤学 | 3431篇 |
出版年
2023年 | 258篇 |
2022年 | 205篇 |
2021年 | 894篇 |
2020年 | 613篇 |
2019年 | 835篇 |
2018年 | 989篇 |
2017年 | 758篇 |
2016年 | 930篇 |
2015年 | 992篇 |
2014年 | 1341篇 |
2013年 | 1810篇 |
2012年 | 2732篇 |
2011年 | 2779篇 |
2010年 | 1595篇 |
2009年 | 1438篇 |
2008年 | 2489篇 |
2007年 | 2437篇 |
2006年 | 2190篇 |
2005年 | 2189篇 |
2004年 | 2008篇 |
2003年 | 1809篇 |
2002年 | 1693篇 |
2001年 | 548篇 |
2000年 | 512篇 |
1999年 | 553篇 |
1998年 | 301篇 |
1997年 | 251篇 |
1996年 | 201篇 |
1995年 | 258篇 |
1994年 | 231篇 |
1993年 | 209篇 |
1992年 | 352篇 |
1991年 | 330篇 |
1990年 | 349篇 |
1989年 | 300篇 |
1988年 | 233篇 |
1987年 | 199篇 |
1986年 | 230篇 |
1985年 | 257篇 |
1984年 | 174篇 |
1983年 | 138篇 |
1982年 | 117篇 |
1981年 | 78篇 |
1980年 | 85篇 |
1979年 | 131篇 |
1977年 | 71篇 |
1976年 | 57篇 |
1975年 | 71篇 |
1974年 | 67篇 |
1973年 | 68篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
Ruscitti Piero Di Cola Ilenia Berardicurti Onorina Conforti Alessandro Iacono Daniela Pantano Ilenia Rozza Gelsomina Rossi Silvia De Stefano Ludovico Balduzzi Silvia Vitale Antonio Caso Francesco Costa Luisa Prete Marcella Navarini Luca Atzeni Fabiola Guggino Giuliana Perosa Federico Cantarini Luca Frediani Bruno Montecucco Carlomaurizio Ciccia Francesco Giacomelli Roberto Cipriani Paola 《Clinical rheumatology》2022,41(11):3597-3597
Clinical Rheumatology - 相似文献
2.
Rizzo Giuseppe Pietrolucci Maria Elena Capponi Alessandra Mappa Ilenia 《The international journal of cardiovascular imaging》2022,38(5):1017-1019
The International Journal of Cardiovascular Imaging - 相似文献
3.
Olivari Davide De Giorgio Daria Staszewsky Lidia Irene Fumagalli Francesca Boccardo Antonio Novelli Deborah Manfredi Martina Babini Giovanni Luciani Anita Ruggeri Laura Magliocca Aurora Zani Davide Danilo Masson Serge Belloli Angelo Pravettoni Davide Maiocchi Giuseppe Latini Roberto Ristagno Giuseppe 《Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy》2022,36(4):727-738
Cardiovascular Drugs and Therapy - Available animal models of acute heart failure (AHF) and their limitations are discussed herein. A novel and preclinically relevant porcine model of decompensated... 相似文献
4.
5.
6.
Aldo Cannata Silvia Cantoni Antonio Sciortino Giuseppe Bruschi Claudio Francesco Russo 《Journal of the American College of Cardiology》2021,77(18):2323-2334
Mechanical intravascular hemolysis is frequently observed following procedures on heart valves and uncommonly observed in native valvular disease. In most cases, its severity is mild. Nevertheless, it can be clinically significant and even life threatening, requiring multiple blood transfusions and renal replacement therapy. This paper reviews the current knowledge on mechanical intravascular hemolysis in valvular disease, before and after correction, focusing on pathophysiology, approach to diagnosis, and impact of other hematological conditions on the resultant anemia. The importance of a multidisciplinary management is underscored. Laboratory data are provided about subclinical hemolysis that is commonly observed following the implantation of surgical and transcatheter valve prostheses and devices. Finally, clinical scenarios are reviewed and current medical and surgical treatments are discussed, including alternative options for inoperable patients. 相似文献
7.
8.
9.
Rosario Mazzola Giulio Francolini Luca Triggiani Giuseppe Napoli Francesco Cuccia Luca Nicosia Lorenzo Livi Stefano Maria Magrini Matteo Salgarello Filippo Alongi 《Clinical genitourinary cancer》2021,19(3):230-236
BackgroundThe present analysis aims to compare the impact of 18F-fluorocholine (18F-choline) and gallium-68 prostate-specific membrane antigen (68Ga-PSMA) positron emission tomography (PET)-computed tomography (CT)–guided metastases-directed therapies (MDTs) in patients with castration-sensitive oligorecurrent prostate cancer (PC).Materials and MethodsInclusion criteria were: (1) histologically proven prostate adenocarcinoma; (2) evidence of biochemical relapse after primary tumor treatment; (3) ≤ 3 hypermetabolic oligorecurrent lesions detected by 18F-choline or 68Ga-PSMA PET-CT; (4) PET-CT imaging performed in a single nuclear medicine department; (5) patients treated with upfront stereotactic body radiotherapy (SBRT) without hormone therapy; and (6) SBRT delivered with a dose per fraction ≥ 5 Gy. In the case of oligoprogression (≤ 3 lesions outside the previous RT field) after MTD, a further course of SBRT was proposed; otherwise, androgen deprivation therapy (ADT) was administered.ResultsA total of 118 lesions in 88 patients were analyzed. Forty-four (50%) patients underwent 68Ga-PSMA PET-guided SBRT, and the remaining underwent choline PET-based SBRT. The median follow-up was 25 months (range, 5-87 months) for the entire cohort. Overall survival and local control were both 100%. Distant progression occurred in 48 (54.5%) patients, for a median distant progression-free survival of 22.8 months (range, 14.4-28.8 months). The median pre-SBRT prostate-specific antigen was 2.04 ng/mL in the choline PET cohort and 0.58 ng/mL in the PSMA-PET arm. Disease-free survival rates were 63.6% and 34%, respectively, in the 68Ga-PSMA and choline PET group (P = .06). The ADT administration rate was higher after choline-PET–guided SBRT (P = .00) owing to the higher incidence of polymetastatic disease after first-course SBRT compared with 68Ga-PSMA-based SBRT.ConclusionIn the setting of oligorecurrent castration-sensitive PC, PSMA-PET-guided SBRT produced a higher rate of ADT-free patients when compared with the 18F-choline-PET cohort. Randomized trials are advocated. 相似文献